Your shopping cart is currently empty

Hydroxocobalamin (Vitamin B12a), a member of the vitamin B12 family, is a potent cyanide antidote. It effectively reduces cyanide concentrations in cells and plasma, significantly increasing the survival rate in cases of acute cyanide poisoning. Additionally, Hydroxocobalamin is used to improve the metabolic profile and neurocognitive outcomes associated with newborn Cbl-C defects and can normalize plasma levels in patients with vitamin B12 deficiency. It is also utilized in research concerning metabolic and neurological diseases, though it may be associated with the induction of acute kidney injury (AKI).

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 2 mg | $35 | - | In Stock | |
| 5 mg | $56 | - | In Stock | |
| 10 mg | $98 | - | In Stock | |
| 25 mg | $177 | - | In Stock | |
| 50 mg | $289 | - | In Stock | |
| 100 mg | $428 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $146 | - | In Stock |
| Description | Hydroxocobalamin (Vitamin B12a), a member of the vitamin B12 family, is a potent cyanide antidote. It effectively reduces cyanide concentrations in cells and plasma, significantly increasing the survival rate in cases of acute cyanide poisoning. Additionally, Hydroxocobalamin is used to improve the metabolic profile and neurocognitive outcomes associated with newborn Cbl-C defects and can normalize plasma levels in patients with vitamin B12 deficiency. It is also utilized in research concerning metabolic and neurological diseases, though it may be associated with the induction of acute kidney injury (AKI). |
| In vitro | In vitro, Hydroxocobalamin (1 mM, 5 min) significantly reverses the decrease in cardiac papillary muscle contractility induced by sodium cyanide. In fibroblast models, Hydroxocobalamin (500 microM, 10 min) effectively reduces the accumulation of intracellular cyanide [1]. |
| In vivo | In vivo, intravenous injection of Hydroxocobalamin (150 mg/kg) maintains higher systolic blood pressure in both volume-controlled and uncontrolled hemorrhage swine models, with efficacy comparable to whole blood [2]. |
| Synonyms | Vitamin B12a |
| Molecular Weight | 1346.36 |
| Formula | C62H89CoN13O15P |
| Cas No. | 13422-51-0 |
| Smiles | O=C(N)CCC1C=2C=C3[N]4=C(C(=C5[N-]6C7C(CC(=O)N)C5(C)CCC(=O)NCC(OP(=O)([O-])OC8C(O)C(OC8CO)N9C=[N](C=%10C=C(C(=CC%109)C)C)[Co+3]4%116([OH-])[N]2C(=C(C%12=[N]%11C7(C)C(C)(CC(=O)N)C%12CCC(=O)N)C)C1(C)CC(=O)N)C)C)C(CCC(=O)N)C3(C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | ||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (14.85 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.